A leading biotechnology company faced a growing backlog of deviations, causing delays in batch release. While internal teams focused on managing root causes and handling new deviations, they needed external QA expertise to remediate outstanding manufacturing-related deviations and restore production timelines.
QbD Group deployed a team of QA specialists to work on-site, collaborating closely with production teams to eliminate bottlenecks and ensure an uninterrupted batch release process.
About the client
The client is a global biotechnology company specializing in plasma protein therapies and immunology solutions. Its manufacturing site is focused on the development and production of plasma-derived medicines for various therapeutic applications.